|
|
Volumn 10, Issue 1, 2004, Pages 31-32
|
|
Modifying quinolone antibiotics yields new anxiolytics
a
a
b
b
c
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID;
4 AMINOBUTYRIC ACID RECEPTOR;
7 CHLORO 1 ETHYL 6 [(1,2,3,4 TETRAHYDRO 1 NAPHTHYLENYL)AMINO] 4 OXO 1,4 DIHYDROQUINOLINE 3 CARBOXYLIC ACID;
ANXIOLYTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
DIAZEPAM;
FLUMAZENIL;
L 383 417;
QUINOLINE DERIVATIVE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
UNCLASSIFIED DRUG;
4 AMINOBUTYRIC ACID A RECEPTOR;
ANTIINFECTIVE AGENT;
QUINOLONE DERIVATIVE;
RECOMBINANT PROTEIN;
ANIMAL BEHAVIOR;
ANIMAL EXPERIMENT;
ARTICLE;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DOSE RESPONSE;
DRINKING;
DRUG BIOAVAILABILITY;
DRUG BRAIN LEVEL;
DRUG MECHANISM;
EMBRYO;
HUMAN;
HUMAN CELL;
NONHUMAN;
PRIORITY JOURNAL;
PUNISHMENT;
CHEMISTRY;
METABOLISM;
PROTEIN BINDING;
ANIMALIA;
ANTI-ANXIETY AGENTS;
ANTI-INFECTIVE AGENTS;
FLUOROQUINOLONES;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
PROTEIN BINDING;
RECEPTORS, GABA-A;
RECOMBINANT PROTEINS;
|
|
EID: 11144356663
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm967 Document Type: Article |
|
Times cited : (47)
|
|
References (9)
|
